forbidden access is denied server error   forbidden access is denied you do not have permission to view this directory or page using the credentials that you supplied insider trading  accipiter life sciences fund lp  form  sec filings home  archives  products  about  contact  faq  new user sign up  sign in form  filings insider buys significant buys penny stocksinsider buying insider sales insider buy sell ratios stock options insider tradingstock screener insider tradinggraph view insider watch sec filings insider trading  accipiter life sciences fund lp select time period  month  months  months  months  year  years  years  years all data       google     yahoo send this page to   blog    digg    reddit    facebook    stumble    delicious enter stock ticker symbol or cik cik lookup search by company or insider name insiders might sell their shares for any number of reasons but they buy them for only one they think the price will rise  peter lynch  what is insider trading email a friend  historical filings delayed by  months new user sign up for real time data existing user sign in common stock purchase or sale transactiondate reporteddate company symbol insiderrelationship sharestraded averageprice totalamount sharesowned filing sale  pm foresight energy lp felp accipiter capital management llcaccipiter life sciences fund lpaccipiter life sciences fund offshore ltdcandens capital llchoffman gabe owner    indirect view purchase  pm foresight energy lp felp accipiter capital management llcaccipiter life sciences fund lpaccipiter life sciences fund offshore ltdcandens capital llchoffman gabe owner    indirect view purchase  pm foresight energy lp felp accipiter capital management llcaccipiter life sciences fund lpaccipiter life sciences fund offshore ltdcandens capital llchoffman gabe owner    indirect view purchasea  am foresight energy lp felp accipiter capital management llcaccipiter life sciences fund lpaccipiter life sciences fund offshore ltdcandens capital llchoffman gabe owner    indirect view purchase  pm foresight energy lp felp accipiter capital management llcaccipiter life sciences fund lpaccipiter life sciences fund offshore ltdcandens capital llchoffman gabe owner    indirect view purchase  pm foresight energy lp felp accipiter capital management llcaccipiter life sciences fund lpaccipiter life sciences fund offshore ltdcandens capital llchoffman gabe owner    indirect view purchase  pm foresight energy lp felp accipiter capital management llcaccipiter life sciences fund lpaccipiter life sciences fund offshore ltdcandens capital llchoffman gabe owner    indirect view purchase  pm foresight energy lp felp accipiter capital management llcaccipiter life sciences fund lpaccipiter life sciences fund offshore ltdcandens capital llchoffman gabe owner    indirect view a indicate amendment filing   secformcom all rights reserved archives        fri  jul    sec is the us securities and exchange commission edgar is a trademark of the sec secformcom is not affiliated with or approved by the us securities and exchange commission sec terms of use  privacy statement    forbidden access is denied server error   forbidden access is denied you do not have permission to view this directory or page using the credentials that you supplied accipiter life sciences announces nomination of three independent director candidates for election to the penwest pharmaceutical board at the  employer login post jobs job seeker login sign up search life sciences jobs search job title only radius miles km  news  news by subject  news by disease   news by date  search news get our freeindustry enewsletter email       accipiter life sciences announces nomination of three independent director candidates for election to the penwest pharmaceutical ppco board at the  annual meeting tweet   am new york feb  prnewswire  accipiter life sciences fund lp accipiter life sciences announced today that it has nominated gabe hoffman david lohman and eugene i davis for election to the board of directors of penwest pharmaceuticals co the company at the companys  annual meeting of shareholders the company has not announced the date of the annual meeting accipiter life sciences which together with its affiliates beneficially owns  shares or approximately  of the outstanding shares of common stock of the company submitted written notice of the nominations to the companys corporate secretary in a letter dated february   certain information concerning participants accipiter life sciences fund lp accipiter life sciences together with the other participants as defined below intend to make a preliminary filing with the securities and exchange commission sec of a proxy statement and accompanying proxy card to be used to solicit votes for the election of a slate of director nominees at the  annual meeting of shareholders of penwest pharmaceuticals co a washington corporation the company accipiter life sciences advises all shareholders of the company to read the proxy statement when it is available because it will contain important information such proxy statement will be available at no charge on the secs web site at httpwwwsecgov in addition the participants in the solicitation will provide copies of the proxy statement without charge upon request requests for copies should be directed to the participants proxy solicitor the participants in the proxy solicitation are anticipated to be accipiter life sciences fund offshore ltd als fund offshore accipiter life sciences fund ii lp als fund ii accipiter life sciences fund ii offshore ltd als fund ii offshore accipiter life sciences fund ii qp lp als fund ii qp together with accipiter life sciences als fund offshore als fund ii als fund ii offshore als fund ii qp the accipiter entities accipiter capital management llc accipiter management candens capital llc candens capital gabe hoffman david lohman and eugene i davis as of the date of this filing accipiter life sciences als fund ii and als fund ii qp beneficially owned   and  shares of common stock of the company respectively as the general partner of each of accipiter life sciences als fund ii and als fund ii qp candens capital may be deemed to beneficially own the  shares of common stock of the company collectively owned by accipiter life sciences als fund ii and als fund ii qp as of the date of this filing als fund offshore and als fund ii offshore beneficially owned  and  shares of common stock of the company respectively as the investment manager of each of als fund offshore and als fund ii offshore accipiter management may be deemed to beneficially own the  shares of common stock of the company collectively owned by als fund offshore and als fund ii offshore as of the date of this filing mr hoffman may be deemed to beneficially own  shares of common stock collectively owned by the accipiter entities mr hoffman has sole voting and dispositive power with respect to the  shares owned by the accipiter entities each of candens capital accipiter management and gabe hoffman disclaims beneficial ownership of the shares of common stock of the company owned by the accipiter entities except to the extent of its or his pecuniary interest therein currently each of messrs lohman and davis do not beneficially own any shares of common stock of the company as members of a group for the purposes of rule db of the securities exchange act of  as amended each of messrs lohman and davis are deemed to beneficially own the  shares of common stock owned by the accipiter entitiescontact gabe hoffman accipiter capital management llc  read at biospacecom related news penwest pharmaceutical ppco pain drug fails main goal in trial torreypines therapeutics inc tptx to reduce work force to streamline operations endo pharmaceuticals endp and penwest pharmaceutical ppco receive paragraph iv certification notice from actavis for opanar er jacques biton named ceo of deinove endo pharmaceuticals endp and penwest pharmaceutical ppco file lawsuit against impax laboratories inc ipxl relating to opanar er aastrom biosciences inc astm announces transition of duties cfo retires endo pharmaceuticals holdings inc endp and penwest pharmaceutical ppco receive new paragraph iv certification notice from impax laboratories inc ipxl for opanar er bipar sciences inc names hoyoung huh md phd president and chief executive officer penwest pharmaceutical ppco completes patient enrollment in phase iia clinical study of nalbuphine er avi biopharma inc avii names dr leslie hudson as chief executive officer please enable javascript to view the comments powered by disqus comments powered by disqus • biospacecom • penwest pharmaceutical • accipiter life sciences   • biotechpharma  personnel                 accipiter life sciences fund lp  ceo founder businessman  profile directorpedianet  list of ceos founders board members and company directors accipiter life sciences fund lp check out list of companies and businesses related to accipiter life sciences fund lp find out accipiter life sciences fund lp address and contact details view other people related to accipiter life sciences fund lp  coworkers colleagues companions etc address  park avenue th floor new york  ny companies related to accipiter life sciences fund lp cikcompany namepositioncompany addressruralmetro corp de east via de ventura scottsdale orchid cellmark inc us route one princeton foresight energy lp north broadway suite  st louis  accipiter life sciences fund lp on the web persons related to accipiter life sciences fund lp  ruralmetro corp denamepositioncityaccipiter capital management llc owner new yorkaccipiter capital management llc owner new yorkaccipiter life sciences fund ii l pnew yorkaccipiter life sciences fund ii l pnew yorkaccipiter life sciences fund ii offshore ltdnew yorkaccipiter life sciences fund ii offshore ltdnew yorkaccipiter life sciences fund ii qp l pnew yorkaccipiter life sciences fund ii qp l pnew yorkaccipiter life sciences fund offshore ltdnew yorkaccipiter life sciences fund offshore ltdnew yorkbrian o allerysr vp  chief admin officer scottsdalegregory a barberscottsdaleponczak kristine a beianscottsdaleponczak kristine a beiansr vp cfo  secretary scottsdaledonna berlinskivp pao controller scottsdalejack e bruckerpresident  ceo scottsdalejack e bruckerpresident  ceo scottsdalejack e bruckerpresident and ceo scottsdalejack e brucker scottsdalecandens capital llcnew yorkcandens capital llcnew yorkcoliseum capital management llc owner new yorkcoliseum capital management llc owner new yorka conrad conraddirector scottsdaleeugene i davisdirector scottsdalemichael p diminopresident and ceo scottsdaleas falckcopenhagen vas falckcopenhagen vas falckpolititorvet copenhagen vdanmark as falck owner copenhagen vdanmark as falckcopenhagen vdanmark as falck owner polititorvet copenhagen vdanmark as falck owner polititorvet copenhagen vholding as falckcopenhagen vholding as falckcopenhagen vholding as falckpolititorvet copenhagen vholding as falckpolititorvet copenhagen vmickeul b gibsonexecutive vp and coo scottsdalegabe hoffmannew yorkgabe hoffmannew yorkearl p hollanddirector scottsdalelouis g jekeldirector scottsdalecharles r kayenew yorkchristopher e kevanesr vp  general counsel scottsdalekurt krumpermanscottsdalebarry d landonsr vp  natl billings  coll scottsdalejoseph landynew yorkmatthew j majorosscottsdalemohsin y meghjinew yorkkevin mooredirector scottsdalenordic capital v alpha ltdjersey channel islandsnordic capital v alpha ltdchannel islandsnordic capital v alpha ltdchannel islandsnordic capital v ltdjersey channel islandsnordic capital v ltdchannel islandsnordic capital v ltdchannel islandsnordic capital v ltdchannel islandsnordic capital v ltdchannel islandsjeff d perrysr vice president and cio scottsdalechristopher s shackeltondirector new yorkchristopher s shackeltondirector new yorkstadium capital management llcbendtennenbaum capital partners llc owner santa monicatennenbaum  co llcsanta monicamichael e tennenbaumsanta monicamaureen e thompsonscottsdalenicole vigluccinew yorkhenry g walkerdirector scottsdalewarburg pincus  conew yorkwarburg pincus llcnew yorkwarburg pincus partners llcnew yorkwarburg pincus private equity x lpnew yorkwarburg pincus x lpnew yorkwarburg pincus x llcnew yorkwarburg pincus x partners lpnew yorkrobert e wilsondirector scottsdalelouis a witzemandirector scottsdalewp rocket holdings inc owner new yorkwp rocket holdings llcnew yorkpersons related to accipiter life sciences fund lp  orchid cellmark incnamepositioncityaccipiter capital management llc owner new yorkaccipiter capital management llc owner new yorkaccipiter life sciences fund ii l pnew yorkaccipiter life sciences fund ii l pnew yorkaccipiter life sciences fund ii offshore ltdnew yorkaccipiter life sciences fund ii offshore ltdnew yorkaccipiter life sciences fund ii qp l pnew yorkaccipiter life sciences fund ii qp l pnew yorkaccipiter life sciences fund offshore ltdnew yorkaccipiter life sciences fund offshore ltdnew yorkbruce f basarabvp na sales and marketing princetonbruce f basarabvp na sales and marketing princetonjames beerydirector columbiajames beerydirector princetonjames beerychairman of the board princetonjames beerydirector princetonthomas a bolognapresident and ceo princetonthomas a bolognapresident and ceo princetonthomas a bolognapresident and ceo princetonthomas a bolognaprincetonjeffrey s boschwitzvp north america mkt  sales princetonjeffrey s boschwitzvp north america mkt  sales princetonjames t jr boyleburlingtonbridger capital llcnew yorkbridger management llc owner new yorkgordon brownsenior vpglobal lab operation princetongordon brownformer executive officer churchvillecandens capital llcnew yorkcandens capital llcnew yorkcandens capital llcnew yorkjenniffer collins princetonbruce d dalzieldirector princetoneugene i davislivingstonjohn deighanprincetonjohn deighancorporate controller  pao princetonf samuel eberts iiiburlingtonjames m hartdirector princetonwilliam b hayesburlingtonsidney m hechtdirector princetonsidney m hechtdirector princetonsidney m hechtdirector princetongabe hoffmannew yorkgabe hoffmangabe hoffmannew yorksamuel d isalypaul james kellychief executive officer paul james kellychief executive officer princetonpaul james kelly wellesleyphilip b korsantgreenwichlaboratory corp of america holdings owner burlingtonlaboratory corp of america holdings owner burlingtonraymond j landsr vice president and cfo princetonstefan lorenbaltimoreroberto mignonenew yorkdavid m murphycorporate controller pao pfo princetonkenneth d noonandirector kenneth d noonandirector princetonkenneth d noonandirector princetonkenneth d noonandirector princetonpbk holdings incgreenwichgeorge postedirector redwood citygeorge postedirector princetongeorge postedirector princetongeorge postedirector princetonjames francis smithvice president and cfo princetonjames francis smithvice president and cfo princetonmichael e b spicerchief finanical officer michael e b spicerchief finanical officer princetonswiftcurrent offshore ltdnew yorkpartners swiftcurrentnew yorkwilliam john thomasvp  general counsel princetonwilliam john thomasvp  general counsel princetonrobert d tiendirector princetonder vaart sandra d vanburlingtonandrew scott waltonburlingtongordon j wassermandirector princetonnicole williamsdirector nicole williamsdirector princetonnicole williamsdirector princetonnicole williamsdirector princetonziff asset management lp owner greenwichpersons related to accipiter life sciences fund lp  foresight energy lpnamepositioncityaccipiter capital management llc owner new yorkaccipiter life sciences fund offshore ltdnew yorkmichael john beyerpresident  ceo st louismichael john beyerpresident  ceo st louisrashda miriam buttarsen vpgen counsel  corp sec st louisrashda miriam buttarsvp  gen counsel  corp secy st louiscandens capital llcnew yorkg nicholas jr caseydirector st louischristopher cline owner palm beach gardenschristopher clinedirector palm beach gardenschristopher clinest louiscline trust co llcpalm beach gardensjohn franklin dickinsondirector palm beach gardensforesight energy gp llcsaint louisforesight reserves lp owner palm beach gardensforesight reserves lppalm beach gardense hunter harrisondirector wellingtone hunter harrisondirector st louisbennett k hatfielddirector ashlanddaniel s hermanndirector st louisdaniel s hermanndirector saint louisgabe hoffmannew yorkdonald r holcomb owner houstonedward bartow jonesst louisoscar andres martinezsenior vice president  cfo st louisoscar andres martinezsvp  cfo st louisrobert d moorepresident  ceo st louisrobert dean moorest clairsvillechristopher n moravecevp  cco lexingtonchristopher n moravecsenior vice president st louischristopher n moravecsvp  cco st louisjames t murphyst louismurray energy corpst clairsvilleenergy holdings co murrayst clairsvillerobert edward murrayst clairsvillerobert eugene murraydirector st clairsvillerobert e murray trustst clairsvillebrian d sullivandirector bristolpaul h viningrichmond potentially same personnamecitycountryaccipiter life sciences fund lpnew yorknyaccipiter life sciences fund lpaccipiter life sciences fund lpnew yorknyaccipiter life sciences fund lpnew yorkny accipiter life sciences fund lp new york  business profiles business profile document delivery api about      companies  officers home     new york      accipiter life sciences fund lp account   login sign up saved  cart  accipiter life sciences fund lp new york  ny   active accipiter life sciences fund lp was formed on  in new york it is currently active save profile   formation details registration number  status active date of formation  stock ownership nbsp no information available nbsp name history nov   actual accipiter life sciences fund lp locations a address candens capital llc  e rd street new york new york  related companies accipiter life sciences fund lp delaware accipiter life sciences fund lp delaware accipiter life sciences fund lp new york accipiter life sciences fund qp lp new york accipiter life sciences fund ii lp delaware about the area zip code  retail trade is a major industry in this area with  businesses  of total annual payroll in   paid employees for pay period including march   did you know where prestige businesses are concerned new york enjoys both wall street and the strongest financial sector business presence in the nation home document delivery api about   business profiles inc business profile usa europe asia  pacific americas alabama alaska arizona arkansas california colorado connecticut delaware district of columbia florida georgia hawaii idaho illinois indiana iowa kansas kentucky louisiana maine maryland massachusetts michigan minnesota mississippi missouri nevada new hampshire new jersey new york north carolina north dakota ohio oklahoma oregon pennsylvania puerto rico south carolina south dakota tennessee texas utah virginia washington wyoming croatia denmark estonia finland france germany gibraltar ireland isle of man luxembourg netherlands norway poland slovenia spain sweden switzerland turkey united kingdom australia hong kong india new zealand singapore thailand canada colombia dominican republic jamaica jersey mexico nova scotia panama quebec ym biosciences shareholding in company fr × member sign in online member centre cision communications cloud cision pr edition cisionpoint mediasource monitoringevaluation visible intelligence fastfinder my cnw cnw access register for my cnw close × search search go  advanced search close see more news releases in biotechnology medical pharmaceuticals ym biosciences shareholding in company mississauga on jan  cnw  ym biosciences inc amex ymi tsxym aimymba an oncology company that identifies develops and commercializes differentiated products for patients worldwide today announced that it has been notified that accipiter life sciences fund lp and affiliated funds now hold  common shares in the company no of total  issued voting rights share capital accipiter life sciences fund lp   accipiter life sciences fund ii lp   accipiter life sciences fund offshore ltd   accipiter life sciences fund ii offshore ltd   accipiter life sciences fund ii qp lp   the holding of  common shares represents  of the current total issued share capital of the company being  common shares this press release is being issued in order to comply with rule  of the aim rules for companies about ym biosciences ym biosciences inc is an oncology company that identifies develops and commercializes differentiated products for patients worldwide the company has two latestage products nimotuzumab a humanized monoclonal antibody that targets the epidermal growth factor receptor egfr and is approved in several countries for treatment of various types of head and neck cancer and aeroleftm a proprietary inhaleddelivery composition of free and liposomeencapsulated fentanyl in development for the treatment of moderate to severe pain including cancer pain this press release may contain forwardlooking statements which reflect the companys current expectation regarding future events these forwardlooking statements involve risks and uncertainties that may cause actual results events or developments to be materially different from any future results events or developments expressed or implied by such forwardlooking statements such factors include but are not limited to changing market conditions the successful and timely completion of clinical studies the establishment of corporate alliances the impact of competitive products and pricing new product development uncertainties related to the regulatory approval process and other risks detailed from time to time in the companys ongoing quarterly and annual reporting certain of the assumptions made in preparing forwardlooking statements include but are not limited to the following that nimotuzumab will continue to demonstrate a competitive safety profile in ongoing and future clinical trials that aeroleftm will continue to generate positive efficacy and safety data in future clinical trials and that ym and its various partners will complete their respective clinical trials within the timelines communicated in this release we undertake no obligation to publicly update or revise any forwardlooking statements whether as a result of new information future events or otherwise sedar e for further information for further information enquiries thomas fechtner the trout group llc tel   email tfechtnertroutgroupcom james smith the equicom group inc tel   x  email jsmithequicomgroupcom nominated adviser canaccord adams limited ryan gaffney tel     release contains wide tables view fullscreen organization profile gilead sciences inc gilead receives approval in canada for vemlidy™ tenofovir alafenamide for the treatment of chronic hepatitis b virus infection multiple provinces and territories demonstrate leadership in the treatment of hivaids by providing access to genvoya® québec demonstrates leadership in the treatment of hivaids by providing access to genvoya® more on this organization custom packages browse our custom packages or build your own to meet your unique communications needs start today cnw membership fill out a cnw membership form or contact us at    learn about cnw services request more information about cnw products and services or call us at    sec info  accipiter life sciences fund lp et al  �� for  re orchid cellmark inc sec info uses javascript� to view pages properly enable javascript in your browser ����sec info������home������search������my interests������help������sign in������please sign in accipiter life sciences fund lp et al � ���for� re�orchid cellmark incon� friday  at pm et � � � for�  � � � as�  owner and other � � � accession �  � � � file �  previous ‘’� ‘’ on  for  � � � next� ‘’ on  for  � � � latest� ‘’ on  for  ��in� this entire filing an entity search ��show� docs searched �and� every hit the st hit help�wildcards�  any letter�  many� logic� for docs� �and� �or� for text� �anywhere� �near� � ↓bottom � t as of filer filing for�on�as docssize issuer agent  accipiter life sciences fund lp  ownoth k orchid cellmark inc olshan frome wolosky llp accipiter life sciences fund offshore ltd hoffman gabe accipiter capital management llc accipiter life sciences fund ii offshore ltd accipiter life sciences fund ii qp lp accipiter life sciences fund ii lp candens capital llcfstatement of change in beneficial ownership of securities � � � form filing table of contents documentexhibit description pages size   statement of change in beneficial ownership of html k securities  accxml dp this document is an xml file that may be rendered in various formatsform  �–� plain text �–� edgar system �–� sec website �–� xml listing �–� xml file�� form  united states securities and exchange commissionwashington dc statement of changes in beneficial ownershipfiled pursuant to section a of the securities exchange act of or section h of the investment company act of  omb approval omb number  estimated average burden hours per response  x check this box if no longer subject to section  form  or form  obligations may continue see instruction b  name and address of reporting person accipiter capital management llc last first middle  park avenue th floor street new york ny  city state zip  issuer name and ticker or trading symbol orchid cellmark inc  orch   relationship of reporting persons to issuer check all applicable ﻿ director x  owner ﻿ officer give title below ﻿ other specify below ﻿  date of earliest transaction monthdayyear   if amendment date of original filed monthdayyear  individual or jointgroup filing check applicable line ﻿ form filed by one reporting person x form filed by more than one reporting person table i  nonderivative securities acquired disposed of or beneficially owned  title of security instr   transaction date monthdayyear a deemed execution date if any monthdayyear  transaction code instr   securities acquired a or disposed of d instr   and   amount of securities beneficially owned following reported transactions instr  and   ownership form direct d or indirect i instr   nature of indirect beneficial ownership instr  code v amount a or d price common stock  par value  ﻿ s ﻿  d   i by alsf offshore ltd  common stock  par value  ﻿ s ﻿  d   i by alsf ii offshore ltd  common stock  par value  ﻿ s ﻿  d   i by alsf ii qp lp  common stock  par value  ﻿ s ﻿  d   i by alsf ii lp  common stock  par value  ﻿ s ﻿  d   i by alsf lp  table ii  derivative securities acquired disposed of or beneficially ownedeg puts calls warrants options convertible securities  title of derivative security instr   conversion or exercise price of derivative security  transaction date monthdayyear a deemed execution date if any monthdayyear  transaction code instr   number of derivative securities acquired a or disposed of d instr   and   date exercisable and expiration date monthdayyear  title and amount of securities underlying derivative security instr  and   price of derivative security instr   number of derivative securities beneficially owned following reported transactions instr   ownership form direct d or indirect i instr   nature of indirect beneficial ownership instr  code v a d date exercisable expiration date title amount or number of shares  name and address of reporting person accipiter capital management llc last first middle  park avenue th floor street new york ny  city state zip  name and address of reporting person candens capital llc last first middle  park avenue th floor street new york ny  city state zip  name and address of reporting person hoffman gabe last first middle  park avenue th floor street new york ny  city state zip  name and address of reporting person accipiter life sciences fund lp last first middle  park avenue th floor street new york ny  city state zip  name and address of reporting person accipiter life sciences fund ii l p last first middle  park avenue th floor street new york ny  city state zip  name and address of reporting person accipiter life sciences fund offshore ltd last first middle  park avenue th floor street new york ny  city state zip  name and address of reporting person accipiter life sciences fund ii offshore ltd last first middle  park avenue th floor street new york ny  city state zip  name and address of reporting person accipiter life sciences fund ii qp l p last first middle  park avenue th floor street new york ny  city state zip explanation of responses � held by accipiter life sciences fund offshore ltd accipiter capital management llc the investment manager of accipiter life sciences fund offshore ltd and gabe hoffman the managing member of accipiter capital management llc disclaim beneficial ownership of these securities except to the extent of their pecuniary interest therein � held by accipiter life sciences fund ii offshore ltd accipiter capital management llc the investment manager of accipiter life sciences fund ii offshore ltd and gabe hoffman the managing member of accipiter capital management llc disclaim beneficial ownership of these securities except to the extent of their pecuniary interest therein � held by accipiter life sciences fund ii qp lp candens capital llc the general partner of accipiter life sciences fund ii qp lp and gabe hoffman the managing member of candens capital llc disclaim beneficial ownership of these securities except to the extent of their pecuniary interest therein � held by accipiter life sciences fund ii lp candens capital llc the general partner of accipiter life sciences fund ii lp and gabe hoffman the managing member of candens capital llc disclaim beneficial ownership of these securities except to the extent of their pecuniary interest therein � held by accipiter life sciences fund lp candens capital llc the general partner of accipiter life sciences fund lp and gabe hoffman the managing member of candens capital llc disclaim beneficial ownership of these securities except to the extent of their pecuniary interest therein ﻿ by accipiter capital management by s gabe hoffman managing member  ﻿ by candens capital llc by s gabe hoffman managing member  ﻿ by s gabe hoffman  ﻿ by accipiter life sciences fund lp by candens capital llc its general partner by s gabe hoffman managing member  ﻿ by accipiter life sciences fund ii lp by candens capital llc its general partner by s gabe hoffman managing member  ﻿ by accipiter life sciences fund offshore ltd by accipiter capital management llc its investment manager by s gabe hoffman managing member  ﻿ by accipiter life sciences fund ii offshore ltd by accipiter capital management llc its investment manager by s gabe hoffman managing member  ﻿ by accipiter life sciences fund ii qp lp by candens capital llc its general partner by s gabe hoffman managing member  ﻿  signature of reporting person date reminder report on a separate line for each class of securities beneficially owned directly or indirectly  if the form is filed by more than one reporting person see instruction  bv  intentional misstatements or omissions of facts constitute federal criminal violations see  usc  and  usc ffa note file three copies of this form one of which must be manually signed if space is insufficient see instruction  for procedure ﻿ transaction code � � s �open market or private sale of nonderivative or derivative security ↑topfiling submission  � – � alternative formats word  rich text html plain text et�al copyright �  fran finnegan  company� all rights reservedabout – privacy – redactions – help — sat  jul  gmt� microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft accipiter fund  money az  web results aol search skip over navigation search the web web images images free online fundraising  raise money online for free today ad · youcaringcom​freefundraising raise money online for free today easy to use start fundraising now how it works testimonials why its free start crowdfunding fundbox™ official site  get paid instantly with fundbox ad · fundboxcom​signup get paid instantly with fundbox join with your invoicing software how it works sign up our pricing learn more about fundbox™ top  mutual funds  find top  mutual funds  searchallcom ad · wwwsearchallcom​mutualfunds search for top  mutual funds with s of results at searchallcom best mutual funds compare mutual funds top  mutual funds top  mutual funds web results hedge fund  accipiter capital management  insider monkey wwwinsidermonkeycomhedgefundaccipitercapitalmanagement accipiter capital management is a new yorkbased healthcare specialist hedge fund that was founded by gabe hoffman in  prior to launching accipiter hoffman  accipiter fund llc in houston tx  company info  reviews httpswwwbizapediacomtxaccipiterfundllchtml discover company info on accipiter fund llc in houston tx such as contacts addresses reviews and registered agent accipiter life sciences fund v helfer  findlaw caselawfindlawcomdecourtofchanceryhtml case opinion for de court of chancery accipiter life sciences fund v helfer read the courts full decision on findlaw accipiter capital management  hedgefundjoblist httpshedgefundjoblistcomaccipitercapitalmanagement accipiter capital management is a hedge fund management company based in new york ny and has approximately  million in assets under management view email aum accipiter capital management  fund info  hedgelistscom httpshedgelistscombloghedgefundmanagerprofilesaccipiter accipiter capital management is a hedge fund based in new york ny accipiter capital management was founded in  and has approximately  million in accipiter life sciences fund offshore ltd  graypools httpswwwgraypoolscomhedgefund view current and historical demographic and financial information for accipiter life sciences fund offshore ltd and other hedge funds accipiter capital management llc – octafinance wwwoctafinancecomhedgefundsaccipitercapitalmanagementllc accipiter capital management llc is a floridabased hedge fund that was founded by gabe hoffman it had more than  million assets under management in june  accipiter capital management llc top holdings httpswhalewisdomcomfileraccipitercapitalmanagementllc accipiter capital management is based out of palm beach gardens accipiter capital management is a hedge fund with  clients and discretionary assets under  accipiter  mutual fund observer discussions httpsmutualfundobservercomdiscussprofileaccipiter heres a statement of the obvious the opinions expressed here are those of the participants not those of the mutual fund observer we cannot vouch for the accuracy  the value gene an interview with paul isaac  barrons wwwbarronscomarticlessb paul isaacs father helped mutual shares founder max heine find his  heine went on to run the legendary mutual shares fund and irving isaac sat on its board for  free online fundraising  raise money online for free today ad · youcaringcom​freefundraising raise money online for free today easy to use start fundraising now how it works testimonials why its free start crowdfunding fundbox™ official site  get paid instantly with fundbox ad · fundboxcom​signup get paid instantly with fundbox join with your invoicing software how it works sign up our pricing learn more about fundbox™ top  mutual funds  find top  mutual funds  searchallcom ad · wwwsearchallcom​mutualfunds search for top  mutual funds with s of results at searchallcom best mutual funds compare mutual funds top  mutual funds top  mutual funds next answers buteo america buteo is the latin name of the common buzzard as both terms are ambiguous buteo is sometimes used instead for example by the peregrine more falconry falcon an austringer german origin flies a hawk accipiter and some buteos and similar or an eagle aquila or similar in modern falconry the more sharpshinned hawk the sharpshinned hawk accipiter striatus is a small hawk with males being the smallest hawks in the united states and canada but with the species more search the web  aol inc all rights reservedprivacy   terms of use   preferences   contact us   powered by bing™ wowcom  part of the aol search network life science  shimadzu scientific instruments gas chromatography liquid chromatography gas chromatographmass spectrometry liquid chromatographmass spectrometry cl series medical devices data management  software molecular spectroscopy elemental analysis life science lab instruments total organic carbon analysis thermal analysis universal testing hardnessviscosity testing particle size analysis highspeed video camera balances xray instruments cannabis testing solutions ceramics metals mining clinical research forensics electronics electronic environmental food beverages life science automotive materials testing energy chemical pharmaceutical plastics polymers and rubber advanced training home    products     life science life science shimadzus life science lab instruments are focused on developing new tools to help accelerate life science research by integrating novel chemistry with innovative technology to achieve a unique position as a true provider of solutions for life scientists shimadzu brings together technologies and tools that help you find out more about your biological sample whether it is a gel based experiment for understanding protein expression characterizing differences in metabolism in patient studies imaging tissue with mass spectrometry shimadzu can help you discover more about the biology of disease courtesy of genomeweb learn about shimadzu’s portfolio of potential clinical proteomics tools pdf life science uvvisnir spectroscopy biospecnano protein sequencing protein sequencer malditof mass spectrometry malditm axima assurance axima confidence axima performance axima resonance megatof™ megadalton maldi glycan analyzer microorganism identification nano spotter integrated sample preparation for lcms clam automated protein separation perfinity workstation perfinity idp dried plasma spots noviplex cards imaging labnirs lightnirs cannabis testing solutions learn more informatics id enterprise informatics service quotationadditional information technical inquiry other inquiry product training order supplies join our enews may  shimadzu’s new nexis gc gas chromatograph offers a modern approach to a classic chromatographic technique march  shimadzu’s new cannabis analyzer for potency provides effortless determination of cannabinoid content february  shimadzu and midi inc partner to bring automated chromatographic data analysis solutions to laboratories of all sizes december  shimadzu’s new lcmsms offers exceptional performance in a robust costeffective design october  shimadzu’s new triple quadrupole gcms achieves world’s highest sensitivity down to femtogram level privacy policy terms of use employment site map copyright c shimadzu scientific instruments all rights reserved product gateway shimadzu scientific instruments gas chromatography liquid chromatography gas chromatographmass spectrometry liquid chromatographmass spectrometry cl series medical devices data management  software molecular spectroscopy elemental analysis life science lab instruments total organic carbon analysis thermal analysis universal testing hardnessviscosity testing particle size analysis highspeed video camera balances xray instruments cannabis testing solutions ceramics metals mining clinical research forensics electronics electronic environmental food beverages life science automotive materials testing energy chemical pharmaceutical plastics polymers and rubber advanced training home    products products gas chromatography gc tracera gc plus gc gca liquid chromatography nexera x crudepure nexera sr iseries iseries analyzers nexera uc nexera quaternary nexera mp prominence prominence uflc prominence uflcxr gas chromatography mass spectrometry gcmstq gcmstq gcmsqp gcmsqp se liquid chromatographmass spectrometry lcms lcms lcms lcms lcms lcmsittof lcms software cl series medical devices learn more data management  software labsolutions labsolutions cs labsolutions db labsolutions lcgc classagent lc driver for waters empower™ gc driver for waters empower™ software cra empower™  software molecular spectroscopy uvvisnir spectroscopy ftir spectroscopy fluorescence spectroscopy elemental analysis atomic absorption spectroscopy inductively coupled plasma emission spectroscopy energy dispersive xray fluorescence spectroscopy wavelength dispersive xray fluorescence spectroscopy xray diffraction life science lab instruments life science uvvisnir spectroscopy automated protein separation protein sequencing peptide synthesis nanotrap biomarker discovery platform malditof mass spectrometry informatics electrophoresis chemical inkjet printer total organic carbon analysis tocl tocvw series online tocvsh toc tnpctnpcc universal testing electromechanical static test frames hydraulic static test frames universal testing frame software trapezium x thermal analysis dsc plus dsc plus with autocooling dtgdtga tmah tgah and tgah dta taws hardness testing  viscosity  flow testing duhduhs mct series hmvg series flowtester capillary rheometers mooney viscometer particle size analysis ig plus saldv sald saldv sald sald saldnano lats wingsald highspeed video camera hypervision hpvx hypervision hpv balances auwd series auw series aux series auy series atxaty series uw series ux series twtwc series txtxbtxc series elb series bwkbxk series animal balances smk specific gravity measurement kit mocu moch quotationadditional information technical inquiry other inquiry product training order supplies join our enews may  shimadzu’s new nexis gc gas chromatograph offers a modern approach to a classic chromatographic technique march  shimadzu’s new cannabis analyzer for potency provides effortless determination of cannabinoid content february  shimadzu and midi inc partner to bring automated chromatographic data analysis solutions to laboratories of all sizes december  shimadzu’s new lcmsms offers exceptional performance in a robust costeffective design october  shimadzu’s new triple quadrupole gcms achieves world’s highest sensitivity down to femtogram level privacy policy terms of use employment site map copyright c shimadzu scientific instruments all rights reserved office locations  shimadzu scientific instruments gas chromatography liquid chromatography gas chromatographmass spectrometry liquid chromatographmass spectrometry cl series medical devices data management  software molecular spectroscopy elemental analysis life science lab instruments total organic carbon analysis thermal analysis universal testing hardnessviscosity testing particle size analysis highspeed video camera balances xray instruments cannabis testing solutions ceramics metals mining clinical research forensics electronics electronic environmental food beverages life science automotive materials testing energy chemical pharmaceutical plastics polymers and rubber home    about shimadzu scientific   office locations office locations if you are searching for a shimadzu location outside of north and south america please click here shimadzu distributor locations for physical measurement distributors click here for north american balance distributors click here for canada click here for mexico centro america the caribbean and parts of south america click here shimadzu north america  shimadzu scientific instruments inc  usa headquarters  riverwood drivecolumbia md   usa phone   fax  products  all shimadzu scientific instruments shimadzu north america regional office  midatlantic  riverwood drivecolumbia md   usa phone  fax  products  all shimadzu scientific instruments shimadzu north america regional office  new england  forest street suite  marlborough ma   usa phone  fax  products  all shimadzu scientific instruments shimadzu north america regional office  new jersey  schoolhouse roadsuite somerset nj   usa phone  fax  products  all shimadzu scientific instruments shimadzu north america regional office  california  koll center parkwaysuite pleasanton ca   usa phone  fax  products  all shimadzu scientific instruments shimadzu north america regional office  north carolina  stirrup creek drivesuite durham nc   usa phone  fax  products  all shimadzu scientific instruments shimadzu north america regional office  chicago  army trail road  suite addison il   usa phone  fax  products  all shimadzu scientific instruments shimadzu north america regional office  kansas  reeder streetlenexa ks   usa phone  fax  products  all shimadzu scientific instruments shimadzu north america regional office  houston  w sam houston pkwy south suite houston tx   usa phone  or  fax  products  all shimadzu scientific instruments shimadzu north america regional office  southern california  palomar point way suite carlsbad ca   usa phone   fax  products  all shimadzu scientific instruments shimadzu usa manufacturing inc  southeast th avenuecanby or   usa phone  fax  products  manufactures shimadzu hplcgcms products infoshimadzusumcom shimadzu medical systems  s vermont avetorrance ca   usa phone  fax  products  medical systemsequipment infoshimadzumedcom shimadzu precision instruments  n lakewood blvd long beach ca   usa phone  fax  products  aircraft equipment infospiinccom kratos analytical  red schoolhouse road bldg achestnut ridge ny   usa phone  fax  products  surface tofmaldi xray products dsurmankratoscom corporate information employment section current promotions corporate shimadzu magazine tradeshows and conferences office directions office locations other offices sales rep locator shimadzu in the community signup for our enews iso certified facilities privacy policy terms of use employment site map copyright c shimadzu scientific instruments all rights reserved support shimadzu scientific instruments gas chromatography liquid chromatography gas chromatographmass spectrometry liquid chromatographmass spectrometry cl series medical devices data management  software molecular spectroscopy elemental analysis life science lab instruments total organic carbon analysis thermal analysis universal testing hardnessviscosity testing particle size analysis highspeed video camera balances xray instruments cannabis testing solutions ceramics metals mining clinical research forensics electronics electronic environmental food beverages life science automotive materials testing energy chemical pharmaceutical plastics polymers and rubber home    support support inquiry product inquiry do you have a product related question need a quote on a product technical inquiry do you need technical assistance with your product customer service inquiry need help determining if a part is in stock    chat with customer service click image to activate chat once it loads our customer service hours are am to  pm est need msdssds material safety data sheets order supplies for your instruments external link   consumables accessories manuals and more consumable guides shimadzu global contact external link please feel free to contact us if you have any questions about our products service or support sales representative search  us only to locate the shimadzu representatives closest to you by zip code training are you looking for the training section of our website click here to learn more virtual advisor shimadzu has launched its interactive virtual advisor websites to further enhance customer service iseries virtual advisor prominence virtual advisor nexera virtual advisor tocv virtual advisor tocl virtual advisor tutorials fundamentals of gcms – click here to learn more mailing address shimadzu scientific instruments  riverwood drive columbia md  usa phone number  fax number  quotationadditional information technical inquiry other inquiry product training order supplies join our enews privacy policy terms of use employment site map copyright c shimadzu scientific instruments all rights reserved newsevents shimadzu scientific instruments gas chromatography liquid chromatography gas chromatographmass spectrometry liquid chromatographmass spectrometry cl series medical devices data management  software molecular spectroscopy elemental analysis life science lab instruments total organic carbon analysis thermal analysis universal testing hardnessviscosity testing particle size analysis highspeed video camera balances xray instruments cannabis testing solutions ceramics metals mining clinical research forensics electronics electronic environmental food beverages life science automotive materials testing energy chemical pharmaceutical plastics polymers and rubber advanced training home    newsevents newsevents may   shimadzu’s new nexis gc gas chromatograph offers a modern approach to a classic chromatographic technique march   shimadzu’s new cannabis analyzer for potency provides effortless determination of cannabinoid content february   shimadzu and midi inc partner to bring automated chromatographic data analysis solutions to laboratories of all sizes december   shimadzu’s new lcmsms offers exceptional performance in a robust costeffective design october   shimadzu’s new triple quadrupole gcms achieves world’s highest sensitivity down to femtogram level september   shimadzu’s new integrated hplc bioethanol analyzer offers roundtheclock qc testing at bioethanol production plants more news july   north american pesticide residue workshop fprw august   denver xray conference august   aaccmass spectrometry in the clinical lab best practices and current applications august   national environmental monitoring conference nemc august   national american chemical society  fall august   cannabis science conference more events  news       events quotationadditional information technical inquiry other inquiry product training order supplies join our enews privacy policy terms of use employment site map copyright c shimadzu scientific instruments all rights reserved